2021
Endovascular and thrombolytic treatment eligibility in childhood arterial ischemic stroke
Hutchinson M, Beslow L, Shih E, Licht D, Kimmel A, Granath C, Ichord R. Endovascular and thrombolytic treatment eligibility in childhood arterial ischemic stroke. European Journal Of Paediatric Neurology 2021, 34: 99-104. PMID: 34454335, DOI: 10.1016/j.ejpn.2021.08.004.Peer-Reviewed Original ResearchConceptsAcute ischemic strokeLarge vessel occlusionEndovascular therapyHyperacute therapyIV-tPAVessel occlusionIschemic strokeMedical contraindicationsScore 6Childhood arterial ischemic strokeIntravenous tissue plasminogen activatorNIH Stroke Scale scoreArterial ischemic strokeStroke Scale scoreSingle-center cohortMild neurologic deficitsTime of presentationComplete vessel occlusionTissue plasminogen activatorChildren ages 2Hyperacute treatmentClinical characteristicsNeurologic deficitsStroke pathwayTreatment eligibility
2019
Potential eligibility for hyperacute treatment in childhood acute arterial ischemic stroke: findings from a single-center 12-year cohort study. (S57.008)
Hutchinson M, Kimmel A, Granath C, Beslow L, Billinghurst L, Licht D, Shih E, Ichord R. Potential eligibility for hyperacute treatment in childhood acute arterial ischemic stroke: findings from a single-center 12-year cohort study. (S57.008). Neurology 2019, 92 DOI: 10.1212/wnl.92.15_supplement.s57.008.Peer-Reviewed Original Research